Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tyler Walburn, Natalie S. Grover, Colette J. Shen, Raghuveer Ranganathan, Christopher Dittus, Anne W. Beaven, Andrew Z. Wang & Kyle Wang. (2021) Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphoma. Leukemia & Lymphoma 62:1, pages 68-75.
Read now
Read now
Dominic P. Decker, Pamela C. Egan, Adam S. Zayac, Diana O. Treaba & Adam J. Olszewski. (2020) Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma. Leukemia & Lymphoma 61:1, pages 198-201.
Read now
Read now
Allison A. Barraclough & Chan Yoon Cheah. (2017) Three different hematologists, three different answers: how should we treat concurrent systemic and central nervous system lymphoma?. Leukemia & Lymphoma 58:9, pages 2021-2023.
Read now
Read now
Articles from other publishers (13)
Juan Pablo Alderuccio, Lakshmi Nayak & Kate Cwynarski. (2023) How I treat secondary CNS involvement by aggressive lymphomas. Blood 142:21, pages 1771-1783.
Crossref
Crossref
Rory Bennett, Anna Ruskova, Christin Coomarasamy, Edward Theakston, Leanne Berkahn, Sharon Jackson, Mina Christophers, Stephen Wong & Samar Issa. (2023)
Diffuse large B‐cell lymphoma at risk of secondary
CNS
involvement: The inefficacy of intravenous high‐dose methotrexate
CNS
prophylaxis and the importance of baseline cerebrospinal fluid analysis
. American Journal of Hematology 98:7, pages 1070-1079.
Crossref
Crossref
Jillian Simard & Mark Roschewski. (2022) SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma. Clinical Lymphoma Myeloma and Leukemia 22:10, pages 709-717.
Crossref
Crossref
Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth A. Christian, Robert A. Baiocchi, Kami Maddocks & Yazeed Sawalha. (2022) Feasibility of high-dose methotrexate administered on day 1 of (R)CHOP in aggressive non-Hodgkin lymphomas. Blood Advances 6:2, pages 460-472.
Crossref
Crossref
Megan Fleming, Ying Huang, Emily Dotson, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan Brammer, Beth Christian, Robert A. Baiocchi, Kami Maddocks & Yazeed Sawalha. (2022) Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study. Therapeutic Advances in Hematology 13, pages 204062072211129.
Crossref
Crossref
Maximilian J. Steinhardt, Franziska C. Krummenast, Andreas Rosenwald, Elena Gerhard-Hartmann, Anke Heidemeier, Hermann Einsele, Max S. Topp & Johannes Duell. (2021) R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement. Journal of Cancer Research and Clinical Oncology 148:1, pages 205-214.
Crossref
Crossref
Yuchen Wu, Xuefei Sun, Xueyan Bai, Jun Qian, Hong Zhu, Qu Cui, Ruixian Xing, Yuedan Chen, Qing Liu, Wenyuan Lai, Junhong Li, Yaming Wang, Shengjun Sun, Nan Ji & Yuanbo Liu. (2021) Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study. Chinese Neurosurgical Journal 7:1.
Crossref
Crossref
Benjamin Thiele, Mascha Binder, Simon Schliffke, Christian Frenzel, Judith Dierlamm, Maxi Wass, Katja C. Weisel, Carsten Bokemeyer & Snjezana Janjetovic. (2021) Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation. Oncology Research and Treatment 44:7-8, pages 375-381.
Crossref
Crossref
Joel C. Wight, Mimi Yue, Colm Keane, Anna Johnston, Kim Linton, Collin Chin, Shin Hnin Wai, Dipti Talaulikar, Robin Gasiorowski, Chan Yoon Cheah, Gareth P. Gregory, Michael Dickinson, Adrian Minson, Caitlin Coombes, Matthew Ku, Stephanie Lam & Eliza A. Hawkes. (2019) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B‐cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. British Journal of Haematology 187:2, pages 174-184.
Crossref
Crossref
Chava Perry, Sharon Ben Barouch, Neta Goldschmidt, Nadav Sarid, Yair Herishanu, Lev Shvidel, Osnat Bairey, Noa Lavi, Netanel Horowitz, Avraham Avigdor, Eyal Lebel, Orit Sofer, Ron Ram & Irit Avivi. (2019) Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study. American Journal of Hematology 94:9, pages 992-1001.
Crossref
Crossref
Aya Yamashita, Masahiro Tokuda, Masatoshi Matsuo, Junji Irie, Yohei Tateishi & Kazuo Mutsukura. (2019) A case of secondary central nervous system lymphoma presenting marked hypoglycorrhachia著明な髄液糖低下を認めた二次性中枢神経系リンパ腫の1例. Rinsho Shinkeigaku 59:6, pages 365-370.
Crossref
Crossref
Joel C. Wight, Geoffrey Chong, Andrew P. Grigg & Eliza A. Hawkes. (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Reviews 32:5, pages 400-415.
Crossref
Crossref
Tarec Christoffer El-Galaly, Chan Yoon Cheah, Mette Dahl Bendtsen, Grzegorz S. Nowakowski, Roopesh Kansara, Kerry J. Savage, Joseph M. Connors, Laurie H. Sehn, Neta Goldschmidt, Adir Shaulov, Umar Farooq, Brian K. Link, Andrés J.M. Ferreri, Teresa Calimeri, Caterina Cecchetti, Eldad J. Dann, Carrie A. Thompson, Tsofia Inbar, Matthew J. Maurer, Inger Lise Gade, Maja Bech Juul, Jakob W. Hansen, Staffan Holmberg, Thomas S. Larsen, Sabrina Cordua, N. George Mikhaeel, Martin Hutchings, John F. Seymour, Michael Roost Clausen, Daniel Smith, Stephen Opat, Michael Gilbertson, Gita Thanarajasingam & Diego Villa. (2018) Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. European Journal of Cancer 93, pages 57-68.
Crossref
Crossref